treatment failure phenotype
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| beta activity | biomarker_for | treatment failure | — | 1 |
| buprenorphine | risk_factor_for | treatment failure | — | 1 |
Mentioned in (8)
Papers in which this entity is mentioned.
- Cell-free DNA technologies for the analysis of brain cancer. (2022)
- Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis. (2021)
- Application of third-generation sequencing in cancer research. (2021)
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. (2021)
- Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in -rearranged lung cancer. (2019)
- Clonal evolution in hematological malignancies and therapeutic implications. (2014)
- Molecular genetics of B-precursor acute lymphoblastic leukemia. (2012)
- EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. (2008)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| treatment failure | phenotype | 8 | 10 |